Jing Hu is a notable inventor based in Foster City, CA, who has made significant strides in the field of cancer treatment. With a focus on developing effective methods for combating various forms of cancer, he has contributed to the advancement of medical science through his innovative patents.

Latest Patents

Jing Hu holds 2 patents related to methods for treating cancers. His latest patents disclose methods for treating cancer in subjects, including humans, who are in need of therapeutic intervention. These methods involve administering a therapeutically effective amount of a specific compound or its pharmaceutically acceptable salt. The patents address cases where the subject may be at very high risk or high risk for cancer, including those who are refractory to chemotherapy or in relapse after treatment. The focus is particularly on hematologic malignancies, such as leukemia and lymphoma.

Career Highlights

Jing Hu is currently employed at Gilead Sciences, Inc., where he continues to work on innovative solutions for cancer treatment. His research and development efforts are aimed at improving patient outcomes and providing new therapeutic options for those affected by cancer.

Collaborations

Throughout his career, Jing Hu has collaborated with esteemed colleagues, including Julie A. Di Paolo and Michael J. Hawkins. These collaborations have fostered a productive environment for innovation and have contributed to the success of his research initiatives.

Conclusion

Jing Hu's contributions to cancer treatment through his patents and work at Gilead Sciences, Inc. highlight his commitment to advancing medical science. His innovative methods offer hope for patients facing challenging cancer diagnoses.

Profile summary based on public USPTO records.